Expert Opinion on Biological Therapy This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Managing adverse events of sacituzumab govitecan
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - October 6, 2023 Category: Drugs & Pharmacology Authors: Ilana SchlamPaolo TarantinoSara M. Tolaneya Department of Hematology and Oncology, Tufts Medical Center, Boston, MA, USAb Department of Medicine, Tufts University, Boston, MA, USAc Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USAd Breast On Source Type: research

An up-to-date review of approved and emerging antibody therapies for idiopathic pulmonary fibrosis
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - October 5, 2023 Category: Drugs & Pharmacology Authors: Jacopo SimonettiGiacomo SgallaLuca Richeldia Unita Operativa Complessa di Pneumologia, Dipartimento di Neuroscienze, Organi di Senso e Torace, Universit à Cattolica del Sacro Cuore, Rome, Italyb Unita Operativa Complessa di Pneumologia, Dipartimento di N Source Type: research

Oncolytic virotherapies for pediatric tumors
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - September 26, 2023 Category: Drugs & Pharmacology Authors: Evan G GrossMohammad A HamoDagoberto Estevez-OrdonezNicholas MB LaskayTravis J AtchleyJames M JohnstonJames M Markerta Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USAb Department of Neurosurgery, Heersink School of Me Source Type: research

Preparing for the third decade of biosimilars
Volume 23, Issue 8, July - December 2023 . (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - September 14, 2023 Category: Drugs & Pharmacology Authors: Ivo AbrahamGuest Editor; Center for Health Outcomes and PharmacoEconomic Research, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, AZ, USA Source Type: research

Current and preclinical treatment options for Merkel cell carcinoma
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - September 11, 2023 Category: Drugs & Pharmacology Authors: B üke CelikdemirRoland HoubenThibault KervarrecMahtab SamimiDavid Schramaa Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germanyb Department of Pathology, Centre Hospitalier Universitaire De Tours, Tour Source Type: research

Stem cell therapy for acute myocardial infarction: Mesenchymal Stem Cells and induced Pluripotent Stem Cells
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - August 30, 2023 Category: Drugs & Pharmacology Authors: Diana ClavellinaWayne BalkanJoshua M Harea Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL, USAb Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA Source Type: research

The importance of predicting patient responses to monoclonal antibodies for Crohn ’s disease
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - August 30, 2023 Category: Drugs & Pharmacology Authors: Nisha GaneshStephen B HanauerParambir S DulaiDepartment of Medicine, Division of Gastroenterology and Hepatology, Northwestern University, Chicago, IL, United States of America Source Type: research

Biological therapies for hemophagocytic lymphohistiocytosis: current knowledge and future perspectives
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - August 25, 2023 Category: Drugs & Pharmacology Authors: Lingbo HeChun YangYini WangDepartment of General Practice, Beijing Friendship Hospital, Capital Medical University, Beijing, China Source Type: research

Challenges and opportunities in the development of combination immunotherapy with OX40 agonists
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - August 21, 2023 Category: Drugs & Pharmacology Authors: William L RedmondEarle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA Source Type: research

How can clinical safety and efficacy concerns in stem cell therapy for spinal cord injury be overcome?
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - August 21, 2023 Category: Drugs & Pharmacology Authors: Nader HejratiRaymond WongMohamad KhazaeiMichael G Fehlingsa Division of Genetics and Development, Krembil Research Institute, University Health Network, Toronto, ON, Canadab Division of Neurosurgery and Spine Program, Department of Surgery, University of Source Type: research

Tisagenlecleucel: CAR-T cell therapy for adult patients with relapsed or refractory follicular lymphoma
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - August 21, 2023 Category: Drugs & Pharmacology Authors: Aditi SahaKhushali JhaveriHumaira SarfrazJulio C Chaveza Department of Medicine/Hematology Oncology, University of South Florida, Tampa, FLUSAb Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL USA Source Type: research